Nisa Investment Advisors
LRMR icon

Nisa Investment Advisors’s Larimar Therapeutics LRMR Stock Holding History

Nisa Investment Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53K Sell
503
-6,400
-93% -$25.4K ﹤0.01% 2794
2026
Q1 		$31.1K Buy
6,903
+5,265
+321% +$21K ﹤0.01% 1862
2025
Q4 		$6.24K Hold
1,638
– – ﹤0.01% 2397
2025
Q3 		$5.29K Hold
1,638
– – ﹤0.01% 2428
2025
Q2 		$4.73K Sell
1,638
-2,118
-56% -$4.9K ﹤0.01% 2457
2025
Q1 		$8.07K Buy
+3,756
New +$11.9K ﹤0.01% 2150
2024
Q4 		– Sell
-118
Closed -$773 – 3029
2024
Q3 		$773 Buy
118
+69
+141% +$555 ﹤0.01% 2632
2024
Q2 		$355 Buy
49
+46
+1,533% +$352 ﹤0.01% 2746
2024
Q1 		$23 Buy
+3
New +$23 ﹤0.01% 2776

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Nisa Investment Advisors's LRMR Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Larimar Therapeutics (LRMR) stake by 93% in Q2 2026, selling an estimated $25.4K and leaving 503 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

Nisa Investment Advisors first reported a position in LRMR in Q1 2024 and has held it in 9 quarters since. The position peaked at $31.1K in Q1 2026. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Nisa Investment Advisors held 503 shares of Larimar Therapeutics worth $1.53K as of Q2 2026.
  • Nisa Investment Advisors sold 6,400 Larimar Therapeutics shares in Q2 2026, an estimated $25.4K.
  • Larimar Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2794 holding.
  • Nisa Investment Advisors first reported a position in Larimar Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Nisa Investment Advisors's Larimar Therapeutics position peaked at $31.1K in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.